SAIMA MAQSOOD: Open Payments
NPI 1629276985 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152 in 7 payments from 5 companies in 2025. Trend: 2023 $63 · 2024 $70 · 2025 $152
Food & beverage: $152
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Alkermes, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $17 |
Products named: HETLIOZ, ARISTADA, AUSTEDO XR, INVEGA SUSTENNA, SPRAVATO, Onyda XR, FANAPT.
Industry payments across MD — which companies pay providers there.
